-
Sector Analysis
Introduction of Drug Exclusivity in China Marks New Era for Drug Innovation
China is shifting from a generic manufacturing base to a global hub for new drug innovation. This transition is increasing the need to strengthen the patent protection system, and data exclusivity will finally be introduced in China soon.
-
Sector Analysis
Rise of High-Priced ATMPs Fuels Demand for More Flexible and Equitable HTA Mechanisms
Over the past few years, the growing influx of advanced therapy medicinal products (ATMPs) has delivered substantial advances in terms of treatment options and even cures for diseases that previously lacked effective therapies. However, these ATMPS often carry substantial development or production costs, and the need for the pharma industry to recover these costs can severely restrict their adoption by health authorities around the world. As such, demand has risen for new, more flexible, more equitable health technology assessment (HTA)...
-
Product Insights
Asthma: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Asthma - Global Clinical Trials Review, 2026" provides an overview of Asthma Clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Rheumatic Disorders: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Rheumatic Disorders - Global Clinical Trials Review, 2026" provides an overview of Rheumatic Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Rheumatic Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Tuberous Sclerosis: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Tuberous Sclerosis - Global Clinical Trials Review, 2026" provides an overview of Tuberous Sclerosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberous Sclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Glioblastoma Multiforme (GBM): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2026" provides an overview of Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data relating to the clinical trials on Glioblastoma Multiforme (GBM). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Cerebral Palsy: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Cerebral Palsy - Global Clinical Trials Review, 2026" provides an overview of Cerebral Palsy Clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Palsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Foot Ulcers: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Diabetic Foot Ulcers - Global Clinical Trials Review, 2026" provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Keratoconjunctivitis Sicca (Dry Eye): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, 2026" provides an overview of Keratoconjunctivitis Sicca (Dry Eye) Clinical trials scenario. This report provides top line data relating to the clinical trials on Keratoconjunctivitis Sicca (Dry Eye). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Ewing Sarcoma: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2026" provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.